<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pulmo</journal-id><journal-title-group><journal-title xml:lang="ru">Пульмонология</journal-title><trans-title-group xml:lang="en"><trans-title>PULMONOLOGIYA</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0869-0189</issn><issn pub-type="epub">2541-9617</issn><publisher><publisher-name>Scientific and Practical Journal “PULMONOLOGIYA” LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">pulmo-3921</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL STUDIES</subject></subj-group></article-categories><title-group><article-title>Иммуноморфологическая характеристика базальных мембран рака легкого</article-title><trans-title-group xml:lang="en"><trans-title>Immunomorphological characteristic of lung cancer basal membranes</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Франк</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Frank</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Отдел патоморфологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Литвинова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Lytvinova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Отдел патоморфологии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Московский научно-исследовательский онкологический институт им. П.А. Герцена</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>1992</year></pub-date><pub-date pub-type="epub"><day>03</day><month>05</month><year>2022</year></pub-date><volume>0</volume><issue>2</issue><fpage>34</fpage><lpage>49</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Франк Г.А., Литвинова Л.В., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Франк Г.А., Литвинова Л.В.</copyright-holder><copyright-holder xml:lang="en">Frank G.A., Lytvinova L.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.pulmonology.ru/pulm/article/view/3921">https://journal.pulmonology.ru/pulm/article/view/3921</self-uri><abstract><p>.</p></abstract><trans-abstract xml:lang="en"><p>49 lung cancer cases with different histologic forms were investigated. The study was performed with the help of cryosta-tic slices with minimal number of artifacts, induced by disguise and destruction of tissue antigens during their histological work-up. The distribution and correlation between the main structural components of basal membranes (BM) — type 4 collagen, laminin and heparansulfateproteoglycane — were studied. It was established that these markers take part in the forming of lung cancer BM. Exept for carcinoid tumors and zones of desmoplasia, the dissociation of markers bears microstructural character. The type 4 collagen, laminin and heparansulfateproteoglycane to a greater extend are elicited in desmoplasia zones and intercellular matrix. The degree of lung cancer BM expression does not depend on the histological form and the level of tissue differentiation of the tumor. That investigation testifies about the different variants of tumor invasion, regardless of its histologic form, the level of differentiation and localization in central or peripheral parts of the lung.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гелыцтейн В. И., Чипышева Т. А., Ермилова. В. Д., Любимов А. В. // Арх. пат.— 1990.— N 9.— С. 12—18.</mixed-citation><mixed-citation xml:lang="en">Гелыцтейн В. И., Чипышева Т. А., Ермилова. В. Д., Любимов А. В. // Арх. пат.— 1990.— N 9.— С. 12—18.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bartek Covarik J., Burchill J. et al. // Molecular Biology and Differentiation of Cancer Cells / Ed. K. Lapis, F. Eckhardk — Basel: Karger, 1987.— P. 123—130.</mixed-citation><mixed-citation xml:lang="en">Bartek Covarik J., Burchill J. et al. // Molecular Biology and Differentiation of Cancer Cells / Ed. K. Lapis, F. Eckhardk — Basel: Karger, 1987.— P. 123—130.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Birembaut P., Caon Y., Adnett J. J., Foidart J. M. // J. Path.— 1985.— Vof. 145.— P: 283—296.</mixed-citation><mixed-citation xml:lang="en">Birembaut P., Caon Y., Adnett J. J., Foidart J. M. // J. Path.— 1985.— Vof. 145.— P: 283—296.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Fisseler-Eckhott A., Preberg M., Foss B., Muller K.-M. // Path. Res. Pract.— 1990.— Vol. 186.— P. 95—101.</mixed-citation><mixed-citation xml:lang="en">Fisseler-Eckhott A., Preberg M., Foss B., Muller K.-M. // Path. Res. Pract.— 1990.— Vol. 186.— P. 95—101.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fisseler-Eckhott A., Voss B., Runze W. P., Muller K.-M. // Atemwegs. Lungenkr.—. 1988,— Bd 14.— S. 375—377.</mixed-citation><mixed-citation xml:lang="en">Fisseler-Eckhott A., Voss B., Runze W. P., Muller K.-M. // Atemwegs. Lungenkr.—. 1988,— Bd 14.— S. 375—377.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Grigiony W. F., Biagini G., Garbisa S. et al. // Amer. J. Path.— 1987.— Vol. 128.— P. 217—224.</mixed-citation><mixed-citation xml:lang="en">Grigiony W. F., Biagini G., Garbisa S. et al. // Amer. J. Path.— 1987.— Vol. 128.— P. 217—224.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Havenith M. G., Arends /. W., Simon R. et al. // Cancer. (Philad.) — 1988.— Vol. 62.— P. 2207—2211.</mixed-citation><mixed-citation xml:lang="en">Havenith M. G., Arends /. W., Simon R. et al. // Cancer. (Philad.) — 1988.— Vol. 62.— P. 2207—2211.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">van den Hooff A. // Advanc. Cancer Res.— 1988.— Vol. 39.— P. 159—196.</mixed-citation><mixed-citation xml:lang="en">van den Hooff A. // Advanc. Cancer Res.— 1988.— Vol. 39.— P. 159—196.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Martin G. M., Timpl R., Kuhn K. // Advanc. Protein Chem.— 1988.— Vol. 39.— P. 1—50.</mixed-citation><mixed-citation xml:lang="en">Martin G. M., Timpl R., Kuhn K. // Advanc. Protein Chem.— 1988.— Vol. 39.— P. 1—50.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Morphological Tumor Markers. General Aspects and-Diagnostic Relevance / Ed. G. Seifert.— Berlin: Springer — Verlag, 1987.— P. 207—244; 82.</mixed-citation><mixed-citation xml:lang="en">Morphological Tumor Markers. General Aspects and-Diagnostic Relevance / Ed. G. Seifert.— Berlin: Springer — Verlag, 1987.— P. 207—244; 82.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Paakko P., Risteli J., Risteli L., Autio-Harmainen И. // Amer. J. surg. Path.— 1990.— Vol. 14.— P. 464—473.</mixed-citation><mixed-citation xml:lang="en">Paakko P., Risteli J., Risteli L., Autio-Harmainen И. // Amer. J. surg. Path.— 1990.— Vol. 14.— P. 464—473.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Timpl R., Dziadek M. // Int. Rev. exp. Path.— 1988.— Vol. 29.— P. 1 — 112.</mixed-citation><mixed-citation xml:lang="en">Timpl R., Dziadek M. // Int. Rev. exp. Path.— 1988.— Vol. 29.— P. 1 — 112.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
